1.5 Abstract in rivista: [1794] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1.361 a 1.380 di 1.794
Titolo Data di pubblicazione Autore(i) File
Matrix metalloproteinases and tissue inhibitor metalloproteinases in hypertensive patients 1-gen-2006 Derosa, Giuseppe; D'Angelo, Angela; Tinelli, C; Ciccarelli, Leonardina; Piccinni, M; Pricolo, F; Salvadeo, S; Ghelfi, M; Ferrari, I; Cicero, A.
Effect of valsartan on adiponectine, leptin and resistine in hypertensive obese patients 1-gen-2006 Fogari, Roberto; Derosa, Giuseppe; Mugellini, Amedeo; Preti, PAOLA STEFANIA; Lazzari, P; Zoppi, A; Destro, M.
Soluble fibres dietary supplementation effect on blood pressure and cardiovascular disease risk of hypertensive overweight patients: A double-blind, randomized clinical trial 1-gen-2007 Cicero, Af; Borghi, C; Bove, M; Manca, M; Laghi, L; Gaddi, Av; Derosa, Giuseppe
Effect of telmisartan on fasting and postprandial inflammation markers in diabetic hypertensive patients 1-gen-2007 Derosa, Giuseppe; Cicero, Afg; D'Angelo, Angela; Celentano, C; Fiorenza, Am; Salvadeo, Sat; Pricolo, F; Ferrari, I; Gravina, A; Fogari, Roberto
Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone: a double-blind, randomised clinical trial 1-gen-2006 Derosa, Giuseppe; D'Angelo, Angela; Ragonesi, Pd; Ciccarelli, Leonardina; Piccinni, Mn; Pricolo, F; Salvadeo, Sat; Gravina, A; Ferrari, I; Fogari, Elena; Cicero, Afg; Fogari, Roberto
Efficacy of soluble fiber supplementation in CVD risk management of patients affected by metabolic syndrome: A 6-months, open-label, RCT 1-gen-2007 Laghi, L; Cicero, Afg; Derosa, Giuseppe; Manca, M; Bove, M; Borghi, C; Gaddi, Av
MMP-2, MMP-9 and their inhibitors and other prothrombotic risk factors plasma level in FCH, MS, FCH plus MS and control subjects 1-gen-2007 Cicero, Afg; Derosa, Giuseppe; Manca, M; Bove, M; Borghi, C; Gaddi, Av
Inflammation markers and MMPS in nondiabetic and diabetic subjects OGTT 1-gen-2007 Derosa, Giuseppe; Cicero, Afg; D'Angelo, Angela; Celentano, C; Fiorenza, Am; Salvadeo, Sat; Pricolo, F; Ferrari, I; Gravina, A; Fogari, Roberto
Efficacy of intensive multi-factorial intervention for cardiovascular disease prevention in high-risk type 2 diabetes: 2-year interim analysis of the MIND.IT study 1-gen-2008 Rivellese, Aa; Vaccaro, O; Ardigo, D; Trovati, M; Cavalot, F; Miccoli, R; Franzini, L; Loreto, Cd; Feo, Pd; Derosa, Giuseppe; Damato, A; Zavaroni, D; Zavaroni, I.
Effect of valsartan-amlodipine combination on inflammation markers, oxidative stress and on assymetric dimethylarginine in type 2 diabetic hypertensive patients 1-gen-2008 Fogari, Roberto; Derosa, Giuseppe; Lazzari, P; Mugellini, Amedeo; Preti, PAOLA STEFANIA; Santoro, T.
Effect of valsartan on adiponectine, leptin, and insulin sensitivity in hypertensive obese patients 1-gen-2007 Fogari, Roberto; Derosa, Giuseppe; Mugellini, Amedeo; Preti, PAOLA STEFANIA; Lazzari, P; Zoppi, A; Destro, M.
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 1-gen-2008 Fogari, Roberto; Derosa, Giuseppe; Preti, PAOLA STEFANIA; Mugellini, Amedeo; Salvadeo, Sa; Zoppi, A; Lazzari, P.
Effect of valsartan-amlodipine combination on inflammation markers, oxidative stress, and asymmetric dimethylarginine in patients with type 2 diabetes and hypertension 1-gen-2008 Fogari, Roberto; Derosa, Giuseppe; Lazzari, P; Mugellini, Amedeo; Preti, PAOLA STEFANIA; Santoro, T.
Atorvastatin addition to losartan or to atenolol and recurrence of paroxysmal atrial fibrillation in hypertension 1-gen-2008 Fogari, Roberto; Derosa, Giuseppe; Zoppi, A; Mugellini, Amedeo; Lazzari, P; Preti, PAOLA STEFANIA; Corradi, L.
Effect of waist circumference reduction on blood pressure in stage I hypertensive normal weight obeses 1-gen-2009 Fogari, Roberto; Derosa, Giuseppe; Zoppi, A; Corradi, L; Preti, PAOLA STEFANIA; Mugellini, Amedeo; Lazzari, P.
Paroxysmal atrial fibrillation and inflammatory markers in essential hypertension 1-gen-2009 Fogari, Roberto; Zoppi, A; Lazzari, P; Preti, PAOLA STEFANIA; Mugellini, Amedeo; Derosa, Giuseppe
Effect of waist circumference reduction on blood pressure in stage 1 hypertensive normal weight obeses 1-gen-2009 Fogari, Roberto; Lazzari, P; Zoppi, A; Preti, PAOLA STEFANIA; Mugellini, Amedeo; Derosa, Giuseppe
Effects of valsartan and olmesartan Addition to amlodipine on ankle oedema in hypertensive patients 1-gen-2009 Fogari, Roberto; Mugellini, Amedeo; Preti, PAOLA STEFANIA; Malamani, G; Corradi, L; Derosa, Giuseppe
Effects of valsartan compared to losartan on insulin resistance parameters in overweight hypertensive patients 1-gen-2009 Fogari, Roberto; Lazzari, P; Corradi, L; Derosa, Giuseppe
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 1-gen-2009 Fogari, Roberto; Preti, PAOLA STEFANIA; Lazzari, P; Mugellini, Amedeo; Zoppi, A; Corradi, L; Derosa, Giuseppe
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1.361 a 1.380 di 1.794
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 1 Contributo su Rivista1794
Autore
  • DEROSA, GIUSEPPE279
  • FOGARI, ROBERTO189
  • CORAZZA, GINO ROBERTO151
  • PRETI, PAOLA STEFANIA148
  • MUGELLINI, AMEDEO137
  • CICCOCIOPPO, RACHELE89
  • BIAGI, FEDERICO86
  • MANZO, LUIGI83
  • CICCARELLI, LEONARDINA73
  • MAGNI, PAOLO69
Data di pubblicazione
  • 2020 - 2026125
  • 2010 - 2019664
  • 2000 - 2009731
  • 1990 - 1999236
  • 1980 - 198932
  • 1972 - 19796
Rivista
  • DIGESTIVE AND LIVER DISEASE112
  • PAGE72
  • JOURNAL OF HYPERTENSION64
  • BLOOD51
  • DIABETES36
  • AMERICAN JOURNAL OF HYPERTENSION32
  • HEPATO-GASTROENTEROLOGY32
  • TOXICOLOGY LETTERS32
  • INTERNAL AND EMERGENCY MEDICINE30
  • EUROPEAN HEART JOURNAL27
Keyword
  • drug development27
  • Mathematical modeling23
  • pharmacokinetic-pharmacodynamic m...20
  • Mathematical modelling of biologi...15
  • heart transplantation13
  • Pharmacodynamics13
  • Pharmacokinetics13
  • Pharmacometrics13
  • preclinical studies13
  • cancer10
Lingua
  • eng1207
  • ita130
  • fre8
  • spa3
  • por1
Accesso al fulltext
  • no fulltext1794